These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 7563154)

  • 21. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
    Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
    Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma.
    Kratzke RA; Otterson GA; Lincoln CE; Ewing S; Oie H; Geradts J; Kaye FJ
    J Natl Cancer Inst; 1995 Dec; 87(24):1870-5. PubMed ID: 7494231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia.
    Zhou M; Gu L; James CD; He J; Yeager AM; Smith SD; Findley HW
    Leukemia; 1995 Jul; 9(7):1159-61. PubMed ID: 7630190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
    Stadler WM; Olopade OI
    Urol Res; 1996; 24(4):239-44. PubMed ID: 8873383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
    Maelandsmo GM; Berner JM; Flørenes VA; Forus A; Hovig E; Fodstad O; Myklebost O
    Br J Cancer; 1995 Aug; 72(2):393-8. PubMed ID: 7640224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM; Pearson JV; Hayward NK
    Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.
    Sumitomo K; Shimizu E; Shinohara A; Yokota J; Sone S
    Int J Oncol; 1999 Jun; 14(6):1075-80. PubMed ID: 10339660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
    Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
    Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of the p16 and p15 genes in human bladder tumors.
    Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
    J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
    Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
    Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.
    Washimi O; Nagatake M; Osada H; Ueda R; Koshikawa T; Seki T; Takahashi T; Takahashi T
    Cancer Res; 1995 Feb; 55(3):514-7. PubMed ID: 7834619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
    Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
    Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J; Kratzke RA; Niehans GA; Lincoln CE
    Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression of P16 and Rb proteins in 106 cases of lung cancer].
    Qin J; Chen G; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.
    Calvano JE; Rush EB; Tan LK; Rosen PP; Borgen PI; Van Zee KJ
    Ann Surg Oncol; 1997; 4(5):416-20. PubMed ID: 9259969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer.
    Hensel CH; Hsieh CL; Gazdar AF; Johnson BE; Sakaguchi AY; Naylor SL; Lee WH; Lee EY
    Cancer Res; 1990 May; 50(10):3067-72. PubMed ID: 2159370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.